Promedior Inc.
This article was originally published in Start Up
Executive Summary
In normal healing, monocytes differentiate into both regulatory macrophages and profibrotic cells known as M2 macrophages and fibrocytes. During fibrosis, that balance is upset and differentiation favors profibrotic cells. Promedior Inc. is developing pentraxin therapeutics designed to control the initiation and progression of fibrosis across a variety of tissues and organ systems.